Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Infectious Disease Control

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 3

Respirable Particulate Matter Exposure Risks Inside and Outside of California Homes and Businesses
Respirable Particulate Matter Exposure Risks Inside and Outside of California Homes and Businesses
12/1/2020 10:17:15 AM
The air quality in California is frequently impacted by everything from smog to wildfire smoke. The quality of air we breathe in, has a significant impact on well-being, considering there are many different types of airborne pollutants that are known to cause health issues.
Apple PPE donation helps Zambia in the fight against COVID-19 and HIV
Apple PPE donation helps Zambia in the fight against COVID-19 and HIV
12/1/2020 8:10:04 AM
At a sprawling warehouse in Lusaka, a truck is loaded with boxes of lifesaving antiretrovirals and begins a two-hour drive west out of Zambia’s capital city.
COVID-19 OSHA Guidance for Employers and Employees in Puerto Rico that Work Indoors with Cloth Face Coverings
COVID-19 OSHA Guidance for Employers and Employees in Puerto Rico that Work Indoors with Cloth Face Coverings
11/30/2020 11:02:54 AM
The COVID-19 pandemic caused many businesses and institutions to temporarily close their doors early this year. As they’ve reopened, employees are typically required to wear face coverings to help prevent the spread of the novel coronavirus.
The Importance of Mold Testing and Monitoring in Healthcare Facilities
The Importance of Mold Testing and Monitoring in Healthcare Facilities
11/30/2020 11:01:29 AM
Over the past several years there have been multiple cases of hospitals temporarily closing parts of their facilities due to the presence of mold. Not only can elevated levels of mold act as a respiratory irritant, allergen and asthma trigger for patients and workers, but some types of mold can cause potentially deadly infections in people.
With Healthier Mobility™, Alstom places innovation at the service of healthier mobility in transport worldwide
With Healthier Mobility™, Alstom places innovation at the service of healthier mobility in transport worldwide
11/30/2020 4:20:16 AM
The unprecedented health crisis encountered since the beginning of 2020 has created new challenges for public transport and mobility all over the world.
Senegal’s UVS uses Atos’ BullSequana Intel-based supercomputer to evaluate impact of COVID-19 containment measures
Senegal’s UVS uses Atos’ BullSequana Intel-based supercomputer to evaluate impact of COVID-19 containment measures
11/27/2020 4:55:29 PM
Atos announces that the Virtual University of Senegal (UVS) is testing a mathematical algorithm which models the spread of COVID-19, to evaluate the impact of containment measures such as social distancing and wearing masks, using Atos’ BullSequana X800 supercomputer.
Every move counts towards better health – says WHO
Every move counts towards better health – says WHO
11/26/2020 2:59:38 AM
Up to 5 million deaths a year could be averted if the global population was more active. At a time when many people are home bound due to COVID-19, new WHO Guidelines on physical activity and sedentary behaviour, launched today, emphasize that everyone, of all ages and abilities, can be physically active and that every type of movement counts.
Coronavirus (COVID-19) Update: FDA Issues New Policy on Dry Heat for Reuse of Certain Respirators
Coronavirus (COVID-19) Update: FDA Issues New Policy on Dry Heat for Reuse of Certain Respirators
11/25/2020 3:12:32 PM
Today, the U.S. Food and Drug Administration (FDA) issued guidance on the use of dry heat to help support the single-user reuse of certain particulate filtering facepiece respirators (FFRs), such as N95 respirators, by health care personnel when there is a limited supply of respirators during the COVID-19 public health emergency.
Fourth iteration of COVID-19 treatment trial underway
Fourth iteration of COVID-19 treatment trial underway
11/25/2020 2:51:30 PM
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced that the fourth iteration of the Adaptive COVID-19 Treatment Trial (ACTT-4) has begun to enroll hospitalized adults with coronavirus disease 2019 (COVID-19) who require supplemental oxygen.
ZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
ZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
11/23/2020 6:15:31 PM
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine.
HHS Allocates Regeneron Therapeutic to Treat Patients With Mild to Moderate COVID-19
HHS Allocates Regeneron Therapeutic to Treat Patients With Mild to Moderate COVID-19
11/23/2020 6:08:43 PM
The U.S. Department of Health and Human Services today announced plans to allocate initial doses of Regeneron’s investigational monoclonal antibody therapeutic, casirivimab and imdevimab, which received emergency use authorization from the U.S.
The drug aprotinin inhibits entry of SARS-CoV2 in host cells
The drug aprotinin inhibits entry of SARS-CoV2 in host cells
11/23/2020 6:06:44 PM
In order for the SARS-CoV2 virus to enter host cells, its “spike” protein has to be cleaved by the cell’s own enzymes – proteases. The protease inhibitor aprotinin can prevent cell infection, as scientists at Goethe University, the University of Kent and the Hannover Medical School have now discovered.
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
11/23/2020 1:54:49 PM
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine.
Tony Blair Institute and Oracle Launch Africa Vaccine Management in the Cloud
Tony Blair Institute and Oracle Launch Africa Vaccine Management in the Cloud
11/23/2020 12:58:34 PM
The Tony Blair Institute (TBI) and Oracle have brought cloud technology to Africa to manage public health programs. Initially, Ghana, Rwanda, and Sierra Leone will use the new Oracle Health Management System to create electronic health records for their vaccination programs for yellow fever, HPV, polio, measles, and COVID-19, as soon as that vaccine is distributed to …
New Consumer Behaviors Will Shift US$3Trillion in Economic Value, Accenture Report Finds
New Consumer Behaviors Will Shift US$3Trillion in Economic Value, Accenture Report Finds
11/23/2020 10:48:30 AM
With the pandemic driving people to spend more time at home, avoid air travel, and change their spending habits, businesses can expect to see a shift of more than US$3 trillion in economic value, according to Accenture (NYSE: ACN).
Survey Says Cost and Complexities of COVID-19 Tests Main Obstacles for Employers
Survey Says Cost and Complexities of COVID-19 Tests Main Obstacles for Employers
11/23/2020 5:39:44 AM
• “Too costly” and “too complicated to implement” were the top two reasons employers gave for not testing employees. • However, many are taking some steps to reduce the risk of spreading the virus.
Preventing Healthcare-Associated Mold Outbreaks in California Hospitals
Preventing Healthcare-Associated Mold Outbreaks in California Hospitals
11/19/2020 1:43:47 PM
In recent times, there have been several hospitals in California that have had to halt operations and temporarily close portions of their facilities after mold was discovered growing indoor.
Data Conversion Laboratory, Court Square Group, and JANA Life Sciences Launch Learning Series on Technology and Content Solutions for Life Sciences Market
Data Conversion Laboratory, Court Square Group, and JANA Life Sciences Launch Learning Series on Technology and Content Solutions for Life Sciences Market
11/19/2020 11:35:15 AM
Data Conversion Laboratory  (DCL),  Court Square Group, and  JANA Life Sciences  announce a learning series for life sciences and biomedical research organizations to dive deep into content structure and cloud-based solutions for managing and safeguarding content in the life sciences.
HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19
HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19
11/19/2020 11:27:43 AM
The U.S. Department of Health and Human Services (HHS) has launched a pilot program with five states to use portable, cartridge-based COVID-19 molecular test kits that provide rapid results.
Social isolation during COVID-19 pandemic linked with high blood pressure
Social isolation during COVID-19 pandemic linked with high blood pressure
11/19/2020 7:52:35 AM
Lockdown due to the COVID-19 pandemic is associated with an increase in high blood pressure among patients admitted to emergency. That’s the finding of a study presented at the 46th Argentine Congress of Cardiology (SAC).